Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Imax Corporation (IMAX) Stock Forecast & Price Prediction Canada | NYSE | Communication Services | Entertainment
$29.16
-0.08 (-0.27%)Did IMAX Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if IMAX is one of their latest high-conviction picks.
Based on our analysis of 19 Wall Street analysts, IMAX has a bullish consensus with a median price target of $32.00 (ranging from $16.00 to $36.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $29.16, the median forecast implies a 9.7% upside. This outlook is supported by 9 Buy, 1 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Eric Handler at Roth Capital, projecting a 23.5% upside. Conversely, the most conservative target is provided by David Karnovsky at JP Morgan, suggesting a 45.1% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for IMAX.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jun 16, 2025 | Rosenblatt | Steve Frankel | Buy | Maintains | $35.00 |
Jun 13, 2025 | Roth Capital | Eric Handler | Buy | Maintains | $36.00 |
Apr 25, 2025 | Macquarie | Chad Beynon | Outperform | Maintains | $32.00 |
Apr 24, 2025 | Rosenblatt | Steve Frankel | Buy | Maintains | $35.00 |
Apr 24, 2025 | Barrington Research | Patrick Sholl | Outperform | Maintains | $32.00 |
Apr 24, 2025 | Wells Fargo | Omar Mejias | Overweight | Maintains | $30.00 |
Apr 11, 2025 | JP Morgan | David Karnovsky | Neutral | Maintains | $26.00 |
Apr 10, 2025 | Benchmark | Mike Hickey | Buy | Reiterates | $30.00 |
Apr 10, 2025 | Rosenblatt | Steve Frankel | Buy | Maintains | $35.00 |
Feb 21, 2025 | JP Morgan | David Karnovsky | Neutral | Maintains | $27.00 |
Feb 20, 2025 | Barrington Research | Patrick Sholl | Outperform | Maintains | $32.00 |
Feb 20, 2025 | Rosenblatt | Steve Frankel | Buy | Maintains | $35.00 |
Feb 20, 2025 | Benchmark | Mike Hickey | Buy | Reiterates | $30.00 |
Feb 20, 2025 | Macquarie | Chad Beynon | Outperform | Maintains | $30.00 |
Feb 20, 2025 | Wells Fargo | Omar Mejias | Overweight | Maintains | $32.00 |
Feb 12, 2025 | Wedbush | Alicia Reese | Outperform | Reiterates | $32.00 |
Jan 30, 2025 | JP Morgan | David Karnovsky | Neutral | Maintains | $25.00 |
Jan 17, 2025 | Benchmark | Mike Hickey | Buy | Reiterates | $30.00 |
Jan 16, 2025 | Rosenblatt | Steve Frankel | Buy | Maintains | $28.00 |
Jan 13, 2025 | Benchmark | Mike Hickey | Buy | Reiterates | $30.00 |
The following stocks are similar to IMAX based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Imax Corporation has a market capitalization of $1.57B with a P/E ratio of 63.4x. The company generates $359.75M in trailing twelve-month revenue with a 7.0% profit margin.
Revenue growth is +9.5% quarter-over-quarter, while maintaining an operating margin of +19.4% and return on equity of +9.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces immersive large-format cinema systems.
Imax Corporation makes money by designing and producing advanced theater systems and partnering with film studios to create IMAX-formatted films. The company operates its own theaters and collaborates with commercial multiplexes, generating revenue through ticket sales, technology licensing, and partnerships.
Imax is known for its superior picture and sound quality, and it continues to innovate in laser projection and audio technologies, maintaining a strong presence in the global film exhibition industry.
Communication Services
Entertainment
700
Mr. Richard Lewis Gelfond J.D.
Canada
1994
IMAX Corporation has increased its share repurchase program by $100 million and extended it to June 30, 2027. The total authorization is now $500 million, with $250 million remaining.
IMAX's $100 million increase in share repurchase signals confidence in its financial health, potentially boosting share prices and benefiting current shareholders by reducing share supply.
IMAX reported a $298 million global box office for Q1, with major releases anticipated. CEO Richard Gelfond discussed summer blockbusters and potential trade impacts on Hollywood.
IMAX's strong box office performance signals robust demand for film experiences, potentially boosting revenue. Upcoming releases may further enhance growth, impacting stock valuations and investor sentiment.
Imax (IMAX) reported earnings 30 days ago; investors may be looking for upcoming developments or guidance regarding the stock's future performance.
IMAX's recent earnings report can impact stock performance, influencing investor sentiment and expectations for future growth or challenges.
EVT (ASX: EVT) and IMAX Corporation (NYSE: IMAX) announced a major expansion, agreeing to install four new IMAX with Laser systems in Australia, tripling EVT's IMAX network by 2027.
The expansion of EVT and IMAX's partnership enhances IMAX's market presence in Australia, potentially increasing revenue and profitability, which could positively impact stock performance.
Regal Cinemas and IMAX announced a partnership expansion, adding four new IMAX with Laser locations, including a major theater at L.A. LIVE in Los Angeles, featuring a large 80-foot screen.
The expansion of Regal Cinemas and IMAX indicates growth potential, enhancing revenue streams and attracting more audiences in major markets, positively impacting both companies' stock performance.
Imax's international revenue performance impacts Wall Street analysts' forecasts and future stock prospects, suggesting potential growth or challenges ahead for investors.
Imax's international revenue impacts Wall Street's forecasts, signaling growth potential or risks that can influence stock performance and investor sentiment.
Based on our analysis of 19 Wall Street analysts, Imax Corporation (IMAX) has a median price target of $32.00. The highest price target is $36.00 and the lowest is $16.00.
According to current analyst ratings, IMAX has 9 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $29.16. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict IMAX stock could reach $32.00 in the next 12 months. This represents a 9.7% increase from the current price of $29.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
Imax Corporation makes money by designing and producing advanced theater systems and partnering with film studios to create IMAX-formatted films. The company operates its own theaters and collaborates with commercial multiplexes, generating revenue through ticket sales, technology licensing, and partnerships.
The highest price target for IMAX is $36.00 from Eric Handler at Roth Capital, which represents a 23.5% increase from the current price of $29.16.
The lowest price target for IMAX is $16.00 from David Karnovsky at JP Morgan, which represents a -45.1% decrease from the current price of $29.16.
The overall analyst consensus for IMAX is bullish. Out of 19 Wall Street analysts, 9 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $32.00.
Stock price projections, including those for Imax Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.